Response to Letter Regarding Article, "Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT".

Authors :: Bohula EA
Giugliano RP
Cannon CP
Zhou J
Murphy SA
White J
Tershakovec AM
Blazing MA
Braunwald E
Source :: Circulation [Circulation] 2016 Mar 29; Vol. 133 (13), pp. e463.
Publication Year :: 2016

Subjects :: Female
Humans
Male
Acute Coronary Syndrome drug therapy
Anticholesteremic Agents therapeutic use
C-Reactive Protein analysis
Cholesterol, LDL blood
Ezetimibe therapeutic use
Simvastatin therapeutic use

Full Text Access

Tools